Suven Pharmaceuticals Limited (NSE:SUVENPHAR)
1,141.00
+30.80 (2.77%)
Mar 28, 2025, 3:30 PM IST
Suven Pharmaceuticals Market Cap
Suven Pharmaceuticals has a market cap or net worth of 293.00 billion as of March 31, 2025. Its market cap has increased by 76.89% in one year.
Market Cap
293.00B
Enterprise Value
287.34B
Revenue
10.48B
Ranking
n/a
PE Ratio
105.28
Stock Price
1,141.00
Market Cap Chart
Since March 9, 2020, Suven Pharmaceuticals's market cap has increased from 33.71M to 293.00B, an increase of 869,219.88%. That is a compound annual growth rate of 501.58%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 28, 2025 | 293.00B | 1.08% |
Dec 31, 2024 | 289.89B | 57.55% |
Dec 29, 2023 | 184.00B | 46.05% |
Dec 30, 2022 | 125.98B | 0.33% |
Dec 31, 2021 | 125.56B | 9.05% |
Dec 31, 2020 | 115.14B | 341,510.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sun Pharmaceutical Industries | 4,162.13B |
Divi's Laboratories | 1,533.20B |
Cipla | 1,164.75B |
Mankind Pharma | 1,000.40B |
Apollo Hospitals Enterprise | 951.31B |
Zydus Lifesciences | 891.93B |
Aurobindo Pharma | 674.02B |
Alkem Laboratories | 583.68B |